Company: LRHC
Filing Date: 2025-08-11
Form Type: S-1
Source: 0001213900-25-074405
Chunk: 10

Company: La Rosa Holdings Corp.
Filing Date: 2025-08-11
Form: S-1
Chunk 10
---
 approval of the Compensation
Committee of the Board of Directors (the “Compensation Committee”) of the Company amended the employment agreement between
the Company and Joseph La Rosa, the Company’s Chief Executive Officer. The amendment provided Mr. La Rosa with a right to receive
certain annual equity awards and milestone equity awards not only in the form of stock options but also in the form of restricted stock
units and amended Section 4.3(b) to include subsection (vii), according to which for every $1,000,000 raised by the Company through financing,
Mr. La Rosa shall be granted an equity award equal to 2% of the outstanding shares of common stock of the Company.

February 2025 Financing and June 2025 Exchange Agreement

On February 4, 2025 (the “Closing Date”),
we entered into a securities purchase agreement (the “SPA”) with an institutional investor (“2025 Investor”) pursuant
to which we agreed to issue and sell to 2025 Investor, upon the terms and conditions set forth in the SPA: (i) a Senior Secured Convertible
Note in the original principal amount of $5,500,000 which matures on the two-year anniversary of the Closing Date (the “Initial
Note”); and (ii) sixteen (16) warrants (“Incremental Warrants”), each to purchase additional Notes in an original principal
amount up to $2,500,000 at an exercise price of $2,256,250, in substantially the same form as the Initial Note (“Incremental Notes”
and together with the Initial Note, the “Notes”). The Incremental Warrants and Initial Note were issued to 2025 Investor on
the Closing Date. The purchase price paid by 2025 Investor under the SPA for the Initial Note and Incremental Warrants was $4,963,750,
which was used by the Company to pay-off certain indebtedness, pay certain outstanding fees and expenses, acquisitions and general corporate
purposes. The Company also granted 2025 Investor registration rights in the shares of common stock issuable pursuant to the SPA and conversion
of the Notes. The Company Group also entered into a security agreement with 2025 Investor pursuant to which the Company Group granted
the 2025 Investor a security interest in certain property of the Company Group to secure the Company’s obligations under the Notes.
The Company also agreed to obtain stockholder approval for the issuance of more than 19.99% of the issued and outstanding common stock